Role of Immunotherapy in the Era of Precision Medicine

Role of Immunotherapy in the Era of Precision Medicine is organized by Society for Translational Oncology (STO).

Released: 5/18/2021 
Expires: 5/19/2022 

Target Audience
Physicians who wish to advance their current knowledge of applications of immunotherapy in personalized cancer care.

Learning Objectives:
• Identify emerging strategies for use of cancer immunotherapy in solid tumor oncology
• Summarize the clinical applications and limitations of predictive biomarkers of immune checkpoint inhibitors
• Develop a translational framework for evaluating additional IO biomarkers